---
title: "TIANYU PHARM: Rosuvastatin and Ezetimibe Tablets (I) Obtained Drug Registration Certificate"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/248017171.md"
description: "According to the Zhitong Finance APP, TIANYU PHARM announced that its wholly-owned subsidiary Zhejiang Nuode Pharmaceutical Co., Ltd. (\"Nuode Pharmaceutical\") recently received the Drug Registration Certificate for Rosuvastatin and Ezetimibe Tablets (I) issued by the National Medical Products Administration (hereinafter referred to as \"National Medical Products Administration\"). Rosuvastatin and Ezetimibe Tablets (I) are suitable for hypercholesterolemia and homozygous familial hypercholesterolemia (HoFH)"
datetime: "2025-07-10T13:32:07.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/248017171.md)
  - [en](https://longbridge.com/en/news/248017171.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/248017171.md)
generator: "portal-rs"
---

# TIANYU PHARM: Rosuvastatin and Ezetimibe Tablets (I) Obtained Drug Registration Certificate

According to the Zhitong Finance APP, TIANYU PHARM (300702.SZ) announced that its wholly-owned subsidiary Zhejiang Nuode Pharmaceutical Co., Ltd. ("Nuode Pharmaceutical") recently received the Drug Registration Certificate for Rosuvastatin and Ezetimibe Tablets (I) issued by the National Medical Products Administration (hereinafter referred to as "NMPA"). Rosuvastatin and Ezetimibe Tablets (I) are suitable for hypercholesterolemia and homozygous familial hypercholesterolemia (HoFH)

### Related Stocks

- [300702.CN](https://longbridge.com/en/quote/300702.CN.md)

## Related News & Research

- [Livzon Pharma buys 3.5% Xinbeijiang Pharma stake for RMB 106.7 million](https://longbridge.com/en/news/296601614.md)
- [FOCUS-As Europe rearms, Italy's fragmented space sector faces a scale test](https://longbridge.com/en/news/296303505.md)
- [CSPC Innovation Pharmaceutical: Biopharma licensing and product launches drove record revenue and profit growth](https://longbridge.com/en/news/296129143.md)
- [SandboxAQ introduces AQPotency for virtual drug screening](https://longbridge.com/en/news/296467103.md)
- [NASA, Katalyst call off SWIFT rescue mission over issues with rescue craft in space](https://longbridge.com/en/news/296388986.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**